Hyaluronic Acid
Polysaccharide with a very high molecular weight which is a component of connective tissue of the organism. As a lubricant, it is a major component of the synovial fluid of the joints, humor vitreo and subcutaneous tissue.
It is used as a topically applied compound for infiltration in the eyes, joints, skin and wounds for healing, cosmetic and surgical purposes.
At latest update no published data on excretion into breast milk were found.
With a high molecular weight, excretion into breast milk seems unlikely.
Because of a low oral bioavailability, the absorption to the infant's plasma from ingested breast milk is greatly impeded.
In addition, it is a natural component of the human body.
Alternatives
We do not have alternatives for Hyaluronic Acid since it is relatively safe.
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Synonyms
- Hyaluronan
- Hylan B
- Hylan G-F 20
- Sodium hyaluronate
Writings
- Υαλουρονικό οξύ (Greek)
- Гиалуроновая Кислота (Cyrillic)
- ヒアルロン酸 (Japanese)
Drug trade names
- Adant™
- Amvisc™
- Aquify™
- Artelac Advanced™
- Artflex™
- Arthryal™
- Artroject™
- Artzal™
- Artz™
- Biolan™
- Biolon™
- Bionect™
- Biosol™
- Biovisc™
- Cicatridina™
- Coease™
- Connettivina™
- Curavisc™
- Curiosin (Куриозин)™
- Curiosin™
- Cystistat™
- Densitium™
- Dropstar™
- Durolane™
- Euflexxa™
- Eyestill (Айстил)™
- Eyestil™
- Fermathron™
- Gengigel™
- Go-On™
- Gonilert™
- Healon (Хеалон)™
- Healon™
- Hialid™
- Hialudorf™
- Hyabak™
- Hyalart™
- Hyalgan (Гиалган)™
- Hyalgan™
- Hyalofill-F™
- Hyalomb™
- Hyalovet Plus™
- Hyalubrix™
- Hyaludermin™
- Hyaluroprol™
- Hyasol™
- HyGel™
- Hylase™
- Hylira™
- Hyruan™
- Ial™
- Iuronicoderm™
- Juvederm Ultra XC™
- Juvederm Voluma XC™
- Juvederm™
- Lagricel Ofteno™
- Lagricel™
- Maxiostenil™
- Miniostenil™
- Monovisc™
- Neolucid Ultra HR™
- NeoVisc™
- Orthovisc™
- Osmolagrimas™
- Oxyal™
- Perlane™
- Polireumin™
- Provisc™
- Recosyn™
- Restylane™
- Shellgel™
- Sinovial™
- Supartz™
- Suplasyn™
- Suprahyal™
- Synoart (Синоарт)™
- Synvisc™
- Toptear™
- Viscoderm™
- Viscoseal™
- Viscure™
- Visiol™
- Vislube™
- Vismed™
- VisThesia™
- Yardel™
- Zonaker™
References
- du Souich P. Absorption, distribution and mechanism of action of SYSADOAS. Pharmacol Ther. 2014Abstract
- Monfort J, Benito P. El ácido hialurónico en el tratamiento de la artrosis. [Hyaluronic acid in the treatment of osteoarthritis]. Reumatol Clin. 2006Abstract Full text (in our servers)
- Monfort J, Benito P. [Hyaluronic acid in the treatment of osteoarthritis]. Reumatol Clin. 2006Abstract
- Dahl LB, Dahl IM, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985Abstract Full text (link to original source) Full text (in our servers)